Pages that link to "Q73687564"
Jump to navigation
Jump to search
The following pages link to Coronary heart disease in HIV-infected individuals (Q73687564):
Displaying 50 items.
- Atherosclerosis and infection: is the jury still not in? (Q22241306) (← links)
- Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1 (Q24802369) (← links)
- START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection (Q26753830) (← links)
- Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries (Q26801331) (← links)
- HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: what we know and best directions for future research (Q26827746) (← links)
- Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus (Q26851535) (← links)
- Metabolic syndrome, diabetes, and cardiovascular risk in HIV (Q26853470) (← links)
- Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? (Q27026486) (← links)
- The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice (Q27318414) (← links)
- HIV infection and the risk of acute myocardial infarction (Q27347231) (← links)
- Role of high-sensitivity C-reactive protein measurements in HIV patients (Q28067891) (← links)
- Cardiovascular Complications of HIV-Associated Immune Dysfunction (Q28084981) (← links)
- The end of AIDS: HIV infection as a chronic disease (Q28300749) (← links)
- Myocarditis in CD8-Depleted SIV-Infected Rhesus Macaques after Short-Term Dual Therapy with Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (Q28743987) (← links)
- HIV and its relationship to insulin resistance and lipid abnormalities. (Q30239101) (← links)
- Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy (Q30248286) (← links)
- Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography (Q30457521) (← links)
- Microbial translocation and cardiometabolic risk factors in HIV infection (Q33713895) (← links)
- Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women's interagency HIV study (Q33761167) (← links)
- The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. (Q33807791) (← links)
- Wellens syndrome in HIV-infected patients: Two case reports (Q33818111) (← links)
- Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study (Q33927532) (← links)
- HIV-associated lipodystrophy: a review from a Brazilian perspective (Q33939681) (← links)
- Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE) (Q33944936) (← links)
- Epidemiology of coronary heart disease in patients with human immunodeficiency virus (Q33998067) (← links)
- Th17, gut, and HIV: therapeutic implications (Q34050602) (← links)
- Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease (Q34077477) (← links)
- Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients (Q34079798) (← links)
- Investigation of low-dose ritonavir on human peripheral blood mononuclear cells using gene expression whole genome microarrays (Q34107487) (← links)
- Large vessel adventitial vasculitis characterizes patients with critical lower limb ischemia with as compared to without human immunodeficiency virus infection (Q34110470) (← links)
- Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients (Q34157856) (← links)
- Estrogen receptor-alpha mediates gender differences in atherosclerosis induced by HIV protease inhibitors (Q34335180) (← links)
- Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance (Q34367498) (← links)
- Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort (Q34553819) (← links)
- Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System (Q34564981) (← links)
- Immunologic basis of cardiovascular disease in HIV-infected adults (Q34638205) (← links)
- Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study (Q34694448) (← links)
- T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women (Q34764361) (← links)
- The macrophage: the intersection between HIV infection and atherosclerosis. (Q34898069) (← links)
- Reduced Kidney Function and Preclinical Atherosclerosis in HIV-Infected Individuals: The Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM) (Q35000346) (← links)
- HIV and HAART-Associated Dyslipidemia (Q35020217) (← links)
- Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation (Q35021902) (← links)
- Cardiovascular disease risk in an aging HIV population: not just a question of biology. (Q35064091) (← links)
- HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells (Q35068359) (← links)
- HIV infection and cardiovascular disease in women (Q35070774) (← links)
- High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection (Q35072075) (← links)
- Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients (Q35072103) (← links)
- HIV infection in the elderly (Q35086332) (← links)
- Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease (Q35104006) (← links)
- Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda (Q35107571) (← links)